Board of Directors approved the consolidated financial statements.
· Issued by Sci Pharmtech Corp.
Close
Today's Information
Provided by: SCI Pharmtech, Inc.
SEQ_NO
3
Date of announcement
2022/03/18
Time of announcement
15:18:02
Subject
Board of Directors approved the consolidated
financial statements.
Date of events
2022/03/18
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/18
2.Date of approval by the audit committee:2022/03/18
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):864,217
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):208,089
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):73,658
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):65,506
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):55,696
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):55,696
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.58
11.Total assets end of the period (thousand NTD):4,189,895
12.Total liabilities end of the period
(thousand NTD):869,264
13.Equity attributable to owners of parent end of the
period (thousand NTD):3,320,631
14.Any other matters that need to be specified:NA
